These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36716420)

  • 1. Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research.
    Li X; Liu Q; Xie X; Peng C; Pang Q; Liu B; Han B
    J Med Chem; 2023 Feb; 66(3):1700-1711. PubMed ID: 36716420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing targeted protein degradation for metabolic diseases therapy.
    Zhou QQ; Xiao HT; Yang F; Wang YD; Li P; Zheng ZG
    Pharmacol Res; 2023 Feb; 188():106627. PubMed ID: 36566001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted protein degraders march towards the clinic for neurodegenerative diseases.
    Kumar D; Hassan MI
    Ageing Res Rev; 2022 Jun; 78():101616. PubMed ID: 35378298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ispinesib as an Effective Warhead for the Design of Autophagosome-Tethering Chimeras: Discovery of Potent Degraders of Nicotinamide Phosphoribosyltransferase (NAMPT).
    Dong G; Wu Y; Cheng J; Chen L; Liu R; Ding Y; Wu S; Ma J; Sheng C
    J Med Chem; 2022 Jun; 65(11):7619-7628. PubMed ID: 35588495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancement of targeted protein degradation strategies as therapeutics for undruggable disease targets.
    Kannan MP; Sreeraman S; Somala CS; Kushwah RB; Mani SK; Sundaram V; Thirunavukarasou A
    Future Med Chem; 2023 May; 15(10):867-883. PubMed ID: 37254917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approaches to targeted protein degradation technologies in drug discovery.
    Xue Y; Bolinger AA; Zhou J
    Expert Opin Drug Discov; 2023 Apr; 18(4):467-483. PubMed ID: 36895136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protein induced proximity and targeted degradations by new degraders: concepts, developments, challenges for clinical applications].
    Reboud-Ravaux M
    Biol Aujourdhui; 2024; 218(1-2):41-54. PubMed ID: 39007776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting lipid droplets for autophagic degradation by ATTEC.
    Fu Y; Lu B
    Autophagy; 2021 Dec; 17(12):4486-4488. PubMed ID: 34436975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective autophagy as the basis of autophagy-based degraders.
    Takahashi D; Arimoto H
    Cell Chem Biol; 2021 Jul; 28(7):1061-1071. PubMed ID: 34087173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy.
    Fang Y; Wang J; Zhao M; Zheng Q; Ren C; Wang Y; Zhang J
    J Med Chem; 2022 Sep; 65(17):11454-11477. PubMed ID: 36006861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Protein Degradation via Lysosomes.
    Paudel RR; Lu D; Roy Chowdhury S; Monroy EY; Wang J
    Biochemistry; 2023 Feb; 62(3):564-579. PubMed ID: 36130224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted protein degradation via the autophagy-lysosome system: AUTOTAC (AUTOphagy-TArgeting Chimera).
    Ji CH; Lee MJ; Kim HY; Heo AJ; Park DY; Kim YK; Kim BY; Kwon YT
    Autophagy; 2022 Sep; 18(9):2259-2262. PubMed ID: 35722947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted clearance of mitochondria by an autophagy-tethering compound (ATTEC) and its potential therapeutic effects.
    Tan S; Wang D; Fu Y; Zheng H; Liu Y; Lu B
    Sci Bull (Beijing); 2023 Dec; 68(23):3013-3026. PubMed ID: 37940449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the undruggables-the power of protein degraders.
    Zhang C; Liu Y; Li G; Yang Z; Han C; Sun X; Sheng C; Ding K; Rao Y
    Sci Bull (Beijing); 2024 Jun; 69(11):1776-1797. PubMed ID: 38614856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Novel PDEδ Autophagic Degraders: A Case Study of Autophagy-Tethering Compound (ATTEC).
    Bao J; Chen Z; Li Y; Chen L; Wang W; Sheng C; Dong G
    ACS Med Chem Lett; 2024 Jan; 15(1):29-35. PubMed ID: 38229750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TACkling Cancer by Targeting Selective Protein Degradation.
    Noblejas-López MDM; Tébar-García D; López-Rosa R; Alcaraz-Sanabria A; Cristóbal-Cueto P; Pinedo-Serrano A; Rivas-García L; Galán-Moya EM
    Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioorthogonal Aptamer-ATTEC Conjugates for Degradation of Alpha-Synuclein via Autophagy-Lysosomal Pathway.
    Liao X; Qin G; Liu Z; Ren J; Qu X
    Small; 2024 Feb; 20(8):e2306760. PubMed ID: 37821404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy mediated targeting degradation, a promising strategy in drug development.
    Zhang J; Pan X; Ji W; Zhou J
    Bioorg Chem; 2024 Aug; 149():107466. PubMed ID: 38843684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AUTACs: Cargo-Specific Degraders Using Selective Autophagy.
    Takahashi D; Moriyama J; Nakamura T; Miki E; Takahashi E; Sato A; Akaike T; Itto-Nakama K; Arimoto H
    Mol Cell; 2019 Dec; 76(5):797-810.e10. PubMed ID: 31606272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress of small molecules for targeted protein degradation: PROTACs and other technologies.
    Zhao HY; Xin M; Zhang SQ
    Drug Dev Res; 2023 Apr; 84(2):337-394. PubMed ID: 36606428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.